-
Mashup Score: 14
Scientists at Berkeley Lab have developed an automated workflow that could accelerate the discovery of new pharmaceutical drugs and other useful products. The new automated approach could analyze chemical reactions in real time and identify new chemical-reaction products much faster than current laboratory methods.
Source: www.eurekalert.orgCategories: General Medicine News, General NewsTweet
-
Mashup Score: 15Rethinking drug efficacy: Research aims to improve drug development - 2 month(s) ago
ASPIRE to Innovate Postdoctoral Fellow Catherine Leasure is the co-author of a comment article published this month in Nature Reviews Bioengineering addressing the pressing obstacle faced by modern drug …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 13Novel genetic priority score unveiled to enhance target prioritization in drug development - 4 month(s) ago
Driven by the need for a better way to prioritize targets for drug development, the Icahn School of Medicine at Mount Sinai has led the development of a novel “genetic priority score” (GPS) that will …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0ESMO Targeted Anticancer Therapies Congress 2024: Abstracts - 7 month(s) ago
The abstract submission for ESMO TAT 2024 is now open!
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Topic: Drug Development for Ovarian Cancer: Challenges and SuccessesUrsula Matulonis, MD is Chief and Director of the Division of Gynecologic Oncology at the…
Source: www.youtube.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 1OCE Regulatory Science Online Lecture Series - 8 month(s) ago
On-demand webinars about oncology product development and clinical trials
Source: www.fda.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4FDA-AACR-ASA Workshop: Overall Survival in Oncology Clinical Trials - 9 month(s) ago
American Association for Cancer Research (AACR), American Statistical Association (ASA), and U.S. Food and Drug Administration (FDA) are partnering to host a workshop on July 18, 2023, at the Bethesda Marriott Pooks Hill hotel in North Bethesda, MD to discuss the use of overall survival (OS) and other endpoints in oncology clinical trials.
Source: www.aacr.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1How to Apply | NExT - 9 month(s) ago
Last Updated: 01/11/23 Overview The NCI Experimental Therapeutics (NExT) pipeline is designed to assist translation to the clinic of novel therapeutic interventions, either synthetic, natural product, or biologic, arising from academic, private, or government entities. NExT is not a grant mechanism. Approved proposals gain access to drug discovery resources and development…
Source: next.cancer.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0FDA-AACR-ASA Workshop: Overall Survival in Oncology Clinical Trials - 9 month(s) ago
American Association for Cancer Research (AACR), American Statistical Association (ASA), and U.S. Food and Drug Administration (FDA) are partnering to host a workshop on July 18, 2023, at the Bethesda Marriott Pooks Hill hotel in North Bethesda, MD to discuss the use of overall survival (OS) and other endpoints in oncology clinical trials.
Categories: Hem/Oncs, Latest HeadlinesTweet-
Starting now, #OncTwitter! Looking forward to joining the panel for session 1 discussing design of #cancer #clinicaltrials. Streaming Tues 7/18/23 8a-5p ET: https://t.co/4hVIiICo7M. @FDAOncology @AACR @AmstatNews #regulatory #drugdevelopment #MedTwitter #AACRSciencePolicy https://t.co/WmuAj4xV7A https://t.co/eChudvAPI9
-
-
Mashup Score: 0Amyloidosis Forum 2023: ATTR Drug Development - 10 month(s) ago
Recorded and edited interviews for the “Patient Perspectives: Today’s Unmet Need” session at the 2023 Amyloidosis Forum meeting.
Source: YouTubeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Scientists @BerkeleyLab have developed an automated workflow that could accelerate the discovery of new pharmaceutical drugs and other useful products. #DrugDevelopment https://t.co/zBNnaqFazP